Circulatory Archives - Page 20 of 25

News
Acute kidney injury linked with doubled inpatient VTEs
December 8, 2017
TORONTO – Which comes first: the acute kidney injury or the venous thromboembolism?
News
Pharmacomechanical thrombolysis does not reduce post-thrombotic syndrome risk
December 6, 2017
The ATTRACT trial results contrast with recent reports from another randomized trial, known as CAVENT.
News
Benefit of dabigatran over warfarin persists in AF patient subgroups undergoing PCI
December 3, 2017
ANAHEIM, CALIF. – Dabigatran protected against thromboembolic events with less bleeding regardless of stent type, type of concomitant treatment, or indication for PCI.
News
Improving the risk assessment of patients with acute pulmonary embolism
November 21, 2017
Hospital-based physicians inadequately assess for severity of pulmonary embolism in patients and fail to ask for consultations from specialists.
News
Prescribers mostly ignore clopidogrel pharmacogenomic profiling
November 16, 2017
ANAHEIM, CALIF. – Physicians treating ACS patients with an antiplatelet all but ignore their genetically assessed ability to metabolize clopidogrel.
News
Keep PCI patients on aspirin for noncardiac surgery
November 15, 2017
ANAHEIM, CALIF. – Perioperative aspirin is more likely to help than harm PCI patients undergoing noncardiac surgery.
Video
VIDEO: U.S. hypertension guidelines reset threshold to 130/80 mm Hg
November 14, 2017
ANAHEIM, CALIF. – Thirty million Americans became hypertensive overnight.
News
Renal dosing of non–vitamin K antagonist oral anticoagulants in atrial fibrillation is important in preventing thrombotic and bleeding complications
November 9, 2017
Does renal underdosing and overdosing of non–vitamin K antagonist oral anticoagulants (NOACs) impact the risk of thrombotic and bleeding complications?
News
Infections increase risk of idiopathic VTE
November 8, 2017
Beware the increased risk of VTE in patients with infections.
News
Atrial fibrillation boosts VTE risk
October 31, 2017
BARCELONA – Study shows women face higher and more persistent risk.